Medical/Pharmaceuticals
Heads of State Commit to Noncommunicable Disease Global Compact to Save 50 Million Lives by 2030
Michael R. Bloomberg reappointed as WHO Global Ambassador for Noncommunicable Diseases and Injuries New Gallup survey indicates strong global support for policies outlined in WHO report to combat growing public health burden of noncommunicable diseases GENEVA and NEW YORK, Sept. 21, 2022 /PRNews...
2022-09-21 20:12
1293
JDRF Announces Launch of Global Type 1 Diabetes Index
The first-of-its-kind index will raise awareness of the burden and unmet need of people living with type 1 diabetes around the world. NEW YORK, Sept. 21, 2022 /PRNewswire/ -- JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, announces the launch of the Type 1 Diab...
2022-09-21 19:55
1398
MGC Pharmaceuticals Successfully Developed Herbal-inspired Products for Treatment of Long COVID and COVID-19
LONDON, Sept. 21, 2022 /PRNewswire/ -- MGC Pharmaceuticals Ltd. (LSE: MXC), (ASX: MXC), (OTC: MGCLF), is a European based bio-pharma company, focused on developing and supplying affordable (Accessible) and Ethically Produced Plant Inspired Medicines, is helping to solve the mystery of treating Lo...
2022-09-21 17:13
2922
Love Your Heart event to offer tips on overall and heart health
SINGAPORE, Sept. 21, 2022 /PRNewswire/ -- Farrer Park Hospital (FPH) will hold
a health awareness event on Saturday, 24 September at Pek Kio Community Centre.
2022-09-21 13:00
1678
Final IPAX-1 Study Data Confirms Safety and Tolerability Profile for TLX101, Preliminary Efficacy Data
MELBOURNE, Australia, Sept. 21, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today reports the final results from the IPAX-1 Ph I/II study of TLX101 therapy (4-L-[131I] iodo-phenylalanine, or 131 I-IPA) in combination with external beam radiation therapy (EBRT)...
2022-09-21 07:51
1208
Glyscend Therapeutics Releases New Phase 1 Biomarker Results and Initiates Phase 2 Clinical Trial under an IND for GLY-200 as a Potential First-in-Class Type 2 Diabetes Treatment
GLY-200 is a First-in-Class, Oral, Gut-Targeted Approach for Treatment of Type 2 Diabetes and Related Metabolic Conditions Newly Released Phase 1 Biomarker Data is Consistent with Effects of Roux-en-Y Gastric Bypass Surgery and Duodenal Exclusion Devices Initial Data from Phase 2 Trial Evaluatin...
2022-09-21 05:33
1235
Sirnaomics to Present Latest Developments on siRNA Therapeutics for Cancer and GalAhead(TM) Platform Programs at the 2nd Annual Oligonucleotide Therapeutics and Delivery Conference
GAITHERSBURG, Md. and SUZHOU, China, Sept. 20, 2022 /PRNewswire/ -- Sirnaomics
Ltd
2022-09-20 22:40
2689
Pulnovo Medical Released Results From PADN-CFDA Pivotal Trial For The Treatment Of Pulmonary Arterial Hypertension (PAH)
SHANGHAI, Sept. 20, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM platform, today released the positive results from the Pulmonary Artery Denervation (PADN)-CFDA pivotal study on Transcatheter Cardiovascular Therapy conference (TCT 2022),one of the world's most influenti...
2022-09-20 20:30
1895
Menarini and SciClone Sign Exclusive Licensing Agreement to Develop and Commercialize Vaborem® in China to Treat Antimicrobial Resistant Infections
* Vaborem®, a patented combination of meropenem and vaborbactam, is expected to address the rising prevalence of carbapenem-resistant Klebsiella pneumoniae (CRKP) infections inChina * The deal brings together Melinta's innovation, Menarini's cross-regional expertise in registration and market...
2022-09-20 17:00
2072
WuXi Biologics' Drug Substance and Drug Product Facilities Again Approved by U.S. FDA and EMA
WUXI, China, Sept. 20, 2022 /PRNewswire/ --WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that its two Drug Substance (DS) facilities and a Drug Product (DP) facility located in Wuxi city received reg...
2022-09-20 10:48
1695
Unstoppable Rise of Korean Medical Tourism
KHIDI Launches Official Medical Korea Website for Easier Access to Korean
Medical Services
SEOUL, South Korea, Sept. 20, 2022 /PRNewswire/ -- Korea Health Industry
Development Institute (KHIDI) has revamped the official website of Medical
Korea(www.medicalkorea.or.kr
2022-09-20 08:00
3126
Smith+Nephew launches OR3O™ Dual Mobility System in Japan for use in primary and revision hip arthroplasty
Features proprietary OXINIUM™ DH material; eliminates Cobalt Chrome alloy reducing wear and corrosion risks1 LONDON, Sept. 20, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of its OR3O Dual Mobility System for use in prim...
2022-09-20 07:00
2464
RemeGen Announces Preliminary Results of Phase III Confirmatory Study of Telitacicept for Treatment of Systemic Lupus Erythematosus (SLE) in China
YANTAI, China, Sept. 19, 2022 /PRNewswire/ -- RemeGen Co., Ltd. ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a commercial-stage biotechnology company, recently announced the preliminary results of the Phase III confirmatory study of its proprietary novel fusion protein Telitacicept for th...
2022-09-19 21:00
1528
Hummingbird Bioscience Chief Scientific Officer Jerome Boyd-Kirkup to Present at the 2nd Annual VISTA Virtual Symposium
SINGAPORE, Sept. 19, 2022 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, today announced thatJerome Boyd-Kirkup, Ph.D., Hummingbird Bioscience's Chief Scientific Offic...
2022-09-19 20:00
1282
MGI Launches Ultra High Speed DNBSEQ-G99 Gene Sequencer* with Mid to Low Range Throughput
SHENZHEN, China, Sept. 19, 2022 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI) on 9 September officially launched DNBSEQ-G99*, the latest model of the gene sequencer* with mid to low range throughput. As one of the sequencers* with the fastest speed among those with the same throughput in the world,...
2022-09-19 20:00
1875
HistoSonics Announces Published Results of Phase I Liver Tumor Trial
As Company Advances Planning for FDA Submission and Future Growth
MINNEAPOLIS, Sept. 19, 2022 /PRNewswire/ -- HistoSonics, (www.histosonics.com
2022-09-19 19:00
1098
Anyong Biotechnology's Locally Sourced 'Santé Silver Perch Essence' Fulfilling Increasing Demand in The APAC Wellness Industry
KAOHSIUNG, Taiwan, Sept. 19, 2022 /PRNewswire/ -- Taiwan-based Anyong Biotechnology, has created a locally-sourced Santé Silver Perch Essence out of ecologically farmed, certified, and traceable silver perch in major markets such asTaiwan, the United States, Singapore, and Malaysia. As consumers'...
2022-09-19 16:30
1769
From Years to Just One Month: Huawei Cloud's Pangu Drug Molecule Model Accelerates New Drug Discovery
BANGKOK, Sept. 19, 2022 /PRNewswire/ -- On September 19, HUAWEI CONNECT 2022 kicked off inBangkok, Thailand. At the event, Mr. Ken Hu, Rotating and Acting Chairman of Huawei, delivered a keynote titled "Unleash Digital," where he talked about how the company is helping organizations make the most...
2022-09-19 13:11
1807
MagicTouch SCB receives IDE approval for In-Stent Restenosis indication
TAMPA, Fla., Sept. 19, 2022 /PRNewswire/ -- The US FDA has granted an
Investigational Device Exemption (IDE) approval forMagicTouch
2022-09-19 12:20
1883
Antengene Announces ATG-101 Granted Orphan Drug Designation by the U.S. FDA
SHANGHAI and BUCKS COUNTY, Pa., Sept. 20, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines ...
2022-09-19 09:34
1578
Week's Top Stories
Most Reposted
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
[Picked up by 328 media titles]
2024-05-17 07:00Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 321 media titles]
2024-05-15 12:00
Innomix and World Castle Association Pioneer LBMR project at Zhangbi Fortress
[Picked up by 317 media titles]
2024-05-20 13:48
Samsung Electronics Unveils Month-Long Celebration of Esports Events for Students in Southeast Asia
[Picked up by 312 media titles]
2024-05-21 08:00
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 308 media titles]
2024-05-16 15:00
Most Read
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
2024-05-15 12:00
13370
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
2024-05-16 15:00
12787
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
2024-05-16 09:39
11905
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
2024-05-17 07:00
10496
Casio to Release G-SHOCK-Surfrider Foundation Collaboration
2024-05-15 09:00
10224
